Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer

NCT00120211 is registered in ClinicalTrials.gov with International Atomic Energy Agency as lead sponsor.

NCT NCT00120211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00120211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
Lead sponsor
International Atomic Energy Agency
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1998
Completion date
May 31, 2006
Enrollment
855 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer